Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Piro

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Blood|December 15, 1994
Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemiaD J Ellison, R W Sharpe, B A Robbins, et al.
Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive NucleosideE Beutler, L D Piro, A Saven, et al.
Cancer|November 23, 2006
Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153Kristie A Blum, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Blood|August 15, 1993
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemiaB A Robbins, D J Ellison, J C Spinosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancyA Saven, W K Cheung, I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
2-Chlorodeoxyadenosine dose escalation in nonhematologic malignanciesA Saven, H Kawasaki, C J Carrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignanciesB R Meisenberg, W E Miller, R McMillan, et al.
Neuromuscular Disorders : NMD|February 5, 2022
Newborn screening for spinal muscular atrophy: The Wisconsin first year experienceMei W Baker, Sean T Mochal, Sandra J Dawe, et al.
The Journal of Investigative Dermatology|September 2, 2006
Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanomaPeter D Boasberg, Dave S B Hoon, Lawrence D Piro, et al.
AJNR. American Journal of Neuroradiology|January 28, 2017
Diffusion Tensor Imaging of White Matter in Children Born from Preeclamptic GestationsE A Figueiró-Filho, B A Croy, J N Reynolds, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Blood|December 15, 1994
Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemiaD J Ellison, R W Sharpe, B A Robbins, et al.
Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive NucleosideE Beutler, L D Piro, A Saven, et al.
Cancer|November 23, 2006
Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153Kristie A Blum, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Blood|August 15, 1993
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemiaB A Robbins, D J Ellison, J C Spinosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancyA Saven, W K Cheung, I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
2-Chlorodeoxyadenosine dose escalation in nonhematologic malignanciesA Saven, H Kawasaki, C J Carrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignanciesB R Meisenberg, W E Miller, R McMillan, et al.
Neuromuscular Disorders : NMD|February 5, 2022
Newborn screening for spinal muscular atrophy: The Wisconsin first year experienceMei W Baker, Sean T Mochal, Sandra J Dawe, et al.
The Journal of Investigative Dermatology|September 2, 2006
Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanomaPeter D Boasberg, Dave S B Hoon, Lawrence D Piro, et al.
AJNR. American Journal of Neuroradiology|January 28, 2017
Diffusion Tensor Imaging of White Matter in Children Born from Preeclamptic GestationsE A Figueiró-Filho, B A Croy, J N Reynolds, et al.
Pageof 9